Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273592 · ClinicalTrials.gov registry record · NA
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
A NA study of Erectile Dysfunction, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06273592: Recruiting NA study of Erectile Dysfunction, sponsored by Montefiore Medical Center.
NCT06273592 is a NA study of Erectile Dysfunction that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 30 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06273592, a NA study of Erectile Dysfunction, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether erectile function is differentially impacted by a single plant-based meat meal versus a single animal meat meal in healthy men with normal erectile function.
Primary Outcome
Total time (in minutes) when penile rigidity is ≥70% at both the tip and the base of the penis as measured by Rigiscan™ during overnight sleep, divided by the total time (in minutes) of overnight sleep. Overnight sleep is defined as the time in minutes from the onset of the first nocturnal erection to the end of the last nocturnal erection (as measured by Rigiscan™).
Conditions Studied
Interventions
- OTHER Animal-based meal
- OTHER Plant-based meat meal
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-09-19 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06273592 shows while recruiting
NCT06273592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Animal-based meal is the first listed.
NCT06273592 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06273592 about?
NCT06273592 is a clinical study titled "The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.". The goal of this study is to determine whether erectile function is differentially impacted by a single plant-based meat meal versus a single animal meat meal in healthy men with normal erectile function.
What is the current status of trial NCT06273592?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-19. Estimated completion is 2027-06.
What conditions does trial NCT06273592 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT06273592?
The interventions under investigation include: Animal-based meal (OTHER), Plant-based meat meal (OTHER).
Who is sponsoring clinical trial NCT06273592?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06273592 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06273592's enrollment target sits among peer trials
30 24th of 33 higher than 9 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
Penile Lengthening Pre-Penile Prosthesis Implantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI